A Fourkour

Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions.

T. J. de Vries, A Fourkour, Th. Wobbes et al. · PubMed · 1997 · 191 citations

Immunology, Human Melanocytic Lesions, Pathology +19

Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR

T. J. de Vries, A Fourkour, Cornelis J.A. Punt et al. · British Journal of Cancer · 1999 · 78 citations · Full text

Transcription of the MAGE-1 gene and the methylation status of its Ets binding promoter elements

B. L. M. Janssen, L. T. F. Van De Locht, A Fourkour et al. · Melanoma Research · 1999 · 17 citations

Expression of immunotherapy candidate proteins GP100, Mart-1/Melan-A and tyrosinase in human melanocytic lesions and melanoma cell lines

T. J. de Vries, A Fourkour, D. J. Ruiter et al. · Melanoma Research · 1997 · 14 citations

Melanoma Cell Lines, Cancer Immunosurveillance, Melanoma +8

Analysis of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction for tyrosinase and MART-1 after mononuclear cell collection with cell preparation tubes: a comparison with the whole blood guanidinium isothiocyanate RNA isolation method

T. J. de Vries, A Fourkour, C. J. A. Punt et al. · Melanoma Research · 2000 · 14 citations

Blood Cell, Pathology, Peripheral Blood +16